Curcumol and FTY720 synergistically induce apoptosis and differentiation in chronic myelomonocytic leukemia via multiple signaling pathways-Reference-Cited by-同舟云学术

Curcumol and FTY720 synergistically induce apoptosis and differentiation in chronic myelomonocytic leukemia via multiple signaling pathways

Published:2020-12-04 Issue:4 Volume:35 Page:2157-2170
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Zhao Mingri¹,Yang Chaoying¹,Chai Siyu¹,Yuan Yijun¹,Zhang Ji²³,Cao Pengfei⁴,Wang Yanpeng¹,Xiao Xiaojuan¹,Wu Kunlu¹,Yan Huiwen⁵,Liu Jing¹,Sun Shuming¹^ORCID

Affiliation:

1. Molecular Biology Research Center, School of Life Sciences Central South University Changsha China

2. Department of Rheumatology The First Affiliated Hospital of University of South China Hengyang China

3. Department of Clinical Laboratory The First Affiliated Hospital of University of South China Hengyang China

4. Xiangya Hospital Central South University Changsha China

5. Department of Cell Biology, School of Life Sciences Central South University Changsha China

Funder

National Basic Research Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.6968

Reference52 articles.

1. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models;Azuma H.;Cancer Research,2002

2. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid

3. AGE OF ONSET AND TYPE OF LEUKAEMIA

4. Curcumol potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer

5. BH3 domains: intracellular death-ligands critical for initiating apoptosis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcumol: a review of its pharmacology, pharmacokinetics, drug delivery systems, structure–activity relationships, and potential applications;Inflammopharmacology;2024-03-23

2. Insight into modulators of sphingosine-1-phosphate receptor and implications for cardiovascular therapeutics;Journal of Drug Targeting;2024-02-06

3. “Combination treatments of imatinib with astaxanthin and crocin efficiently ameliorate antioxidant status, inflammation and cell death progression in imatinib-resistant chronic myeloid leukemia cells”;Molecular Biology Reports;2024-01-16

4. Curcumol Enhances the Antitumor Effect of Lenvatinib on Hepatocellular Carcinoma Cells;Discovery Medicine;2024

5. Dual inhibition of STAT3 and STAT5 may overcome imatinib resistance in chronic myeloid leukemia;Hematology;2023-06-22